SAAL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.080600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.640600E-01
Normal-vs-Stage2
3.369400E-01
Normal-vs-Stage3
3.370200E-01
Normal-vs-Stage4
5.532000E-01
Stage1-vs-Stage2
6.517400E-01
Stage1-vs-Stage3
7.736000E-01
Stage1-vs-Stage4
5.943600E-01
Stage2-vs-Stage3
4.519800E-01
Stage2-vs-Stage4
8.163000E-01
Stage3-vs-Stage4
5.432000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.171200E-01
Normal-vs-AfricanAmerican
2.830400E-01
Normal-vs-Asian
2.939800E-01
Caucasian-vs-AfricanAmerican
9.672400E-01
Caucasian-vs-Asian
7.791000E-01
AfricanAmerican-vs-Asian
8.073600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.541600E-01
Normal-vs-Female
2.591800E-01
Male-vs-Female
9.356000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.356000E-01
Normal-vs-Age(41-60Yrs)
2.619400E-01
Normal-vs-Age(61-80Yrs)
3.293000E-01
Normal-vs-Age(81-100Yrs)
5.608200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.477800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.376400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.821800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.562200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.652000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.211000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.511200E-01
Normal-vs-Daily Drinker
1.778220E-01
Normal-vs-Weekly Drinker
3.220600E-01
Normal-vs-Occasional Drinker
6.421400E-01
Normal-vs-Social Drinker
5.578000E-01
Non Drinker-vs-Daily Drinker
5.574800E-01
Non Drinker-vs-Weekly Drinker
7.810000E-01
Non Drinker-vs-Occasional Drinker
3.398200E-01
Non Drinker-vs-Social Drinker
6.465600E-01
Daily Drinker-vs-Weekly Drinker
8.163000E-01
Daily Drinker-vs-Occasional Drinker
7.106300E-02
Daily Drinker-vs-Social Drinker
2.683400E-01
Weekly Drinker-vs-Occasional Drinker
2.074200E-01
Weekly Drinker-vs-Social Drinker
4.774800E-01
Occasional Drinker-vs-Social Drinker
6.587400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.765600E-01
Normal-vs-Grade 2
9.794800E-01
Normal-vs-Grade 3
9.560800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.975800E-02
Grade 1-vs-Grade 3
4.476600E-03
Grade 1-vs-Grade 4
8.765600E-01
Grade 2-vs-Grade 3
1.803820E-01
Grade 2-vs-Grade 4
9.794800E-01
Grade 3-vs-Grade 4
9.560800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.494200E-01
Normal-vs-NonDiabetic
2.716000E-01
Diabetic-vs-NonDiabetic
9.589400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.968400E-01
Normal-vs-NoPancreatitis
3.132800E-01
Pancreatitis-vs-NoPancreatitis
7.105800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.982400E-01
Normal-vs-N1
2.284400E-01
N0-vs-N1
6.100100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.537800E-01
Normal-vs-TP53-NonMutant
3.951800E-01
TP53-Mutant-vs-TP53-NonMutant
1.503910E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
